In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.
|Articles|December 1, 2020
- Vol 65 No 11
- Volume 65
- Issue 11
What did you think of the November cover story?
We want to hear from you.
Advertisement
Let Contemporary OB/GYN know what you thought of this month’s cover story, '
Do you agree that laparoscopic abdominal entry is the most dangerous part of any laparoscopic procedure?
Have you practiced shared decision-making with your patients? This peer-reviewed article, '
Let us know: Find us on Facebook and Twitter , or send an email to our editorial staff at COGEditorial@mmhgroup.com.
Read the full digital edition here .
Articles in this issue
almost 6 years ago
Cesarean delivery leads to unexpected outcomealmost 6 years ago
Desquamative inflammatory vaginitisalmost 6 years ago
Why shared decision-making matters more than everalmost 6 years ago
Advancing technology in diabetes managementabout 6 years ago
The state of gynecologic robotic surgeryabout 6 years ago
How much is my idea worth?about 6 years ago
Innovating for improved patient outcomesabout 6 years ago
Abdominal entry in laparoscopic surgeryabout 6 years ago
Vaginal Dilators: A guide for health care professionalsAdvertisement
Related to this article
Mental health, bias, and trauma shape sexual health visits, and histories should assess function, not just risk, according to Sameena Rahman, MD.
This FAQ summarizes a Special Report discussion on off-label testosterone dosing, application, cost, and lab monitoring in women.
This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.
This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.
Kanchi Chadha, MD, FACOG, MSCP, supports reconsidering MHT boxed warnings but says the FDA cited no study behind the change.
HRSA will award up to $1 million to a single organization to update the Women's Preventive Services Guidelines through the new WISH program.
Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule
2
FAQ: How is off-label testosterone dosed and monitored in women?
3
Mental health, bias, and trauma: Building trust in sexual medicine
4
Q&A: Soma Mandal, MD, MSCP, on FDA boxed warning removals for MHT
5